Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.33 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.33 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19119836 | 0.88 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL19080590 | 0.87 | TDP1 (0.41) | ALDH1A1TAS1R3TAS1R1TAS1R2LMNA | |
| SCHEMBL277041 | 0.80 | LMNA (0.50) | ALDH1A1LMNA | |
| SCHEMBL19091354 | 0.80 | ADH1B (0.50) | LMNA | |
| SCHEMBL20988131 | 0.80 | TRPM8 (0.30) | — | |
| SCHEMBL12580592 | 0.76 | — | — | |
| SCHEMBL23613090 | 0.76 | TAS1R3 (0.31) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL83493 | 0.76 | — | — | |
| SCHEMBL16469013 | 0.76 | — | — | |
| SCHEMBL20210214 | 0.74 | TDP1 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090062280-A1 | Ophthalmic Compositions for Treating Ocular Hypertension | MERCK SHARP & DOHME CORP. | 2009-03-05 | — | — | US | disclosed |
| US-20090062280-A1 | Ophthalmic Compositions for Treating Ocular Hypertension | MERCK SHARP & DOHME CORP. | 2009-03-05 | — | — | US | disclosed |
| US-6051360-A | A REACTION PRODUCT OF A CHROMOPHORIC NUCLEUS AND A BISPHENOL; EXCELLENT SOLUBILITY IN SOLVENTS AND BINDER RESINS; COLOR FILTERS FOR DISPLAY DEVICES SUCH AS LIQUID CRYSTAL TELEVISION AND COLOR SEPARATION FILTERS FOR IMAGE PICKUP TUBES | MITSUI CHEMICALS, INC. (JP) | 2000-04-18 | — | — | US | disclosed |
| EP-0519423-B1 | Phthalocyanine compounds and usage thereof | MITSUI CHEMICALS INC (JP) | 1999-03-03 | — | — | EP | disclosed |
| US-5773172-A | SOLVENT AND BINDER SOLUBILITY | MITSUI TOATSU CHEMICALS, INC. (JP) | 1998-06-30 | — | — | US | disclosed |
| EP-0564237-B1 | Preparation of color filter and photo-setting resin therefor | MITSUI TOATSU CHEMICALS (JP) | 1998-03-11 | — | — | EP | disclosed |
| US-5695911-A | CONTAINING PHTHALOCYANINE COMPOUND | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1997-12-09 | — | — | US | disclosed |
| US-5482804-A | Resin composition for color filter | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1996-01-09 | — | — | US | disclosed |
| EP-0633296-A1 | Novel dyestuffs and their use | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1995-01-11 | — | — | EP | disclosed |
| US-5380842-A | Color filters | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1995-01-10 | — | — | US | disclosed |
| EP-0564237-A2 | Preparation of color filter and photo-setting resin therefor | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1993-10-06 | — | — | EP | disclosed |
| EP-0519423-A2 | Phthalocyanine compounds and usage thereof | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1992-12-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062280-A1 | Ophthalmic Compositions for Treating Ocular Hypertension | KCNN3, KCNN1, KCNN2 | ALDH1A1 1707/4885TAS1R3 3028/4885TAS1R1 3364/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.